Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saniya Kari

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Brain Communications|July 11, 2022
Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implicationsManon Galoppin, Saniya Kari, Sasha Soldati, et al.
Frontiers in Immunology|December 17, 2020
Vitamin D/CD46 Crosstalk in Human T Cells in Multiple SclerosisJustin Killick, Joanne Hay, Elena Morandi, et al.
Cancer Immunology Research|January 15, 2026
Conditional IL4I1 inactivation triggers tumor-associated macrophage reprogramming and CD8+ T-cell reactivation to control melanoma progressionMalvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 23, 2025
Sex Bias in IL-10 Production by Type I Regulatory T Cells Regulated by PI3K/mTOR SignalingAymeline Debonlier, Saniya Kari, Florence Bucciarelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2024
Increased levels of circulating soluble CD226 in multiple sclerosisSaniya Kari, Florence Bucciarelli, Thibault Angles, et al.
Nature Communications|July 2, 2025
In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosisBeatriz Chaves, Juan Carlo Santos E Silva, Helder Nakaya, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Brain Communications|July 11, 2022
Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implicationsManon Galoppin, Saniya Kari, Sasha Soldati, et al.
Frontiers in Immunology|December 17, 2020
Vitamin D/CD46 Crosstalk in Human T Cells in Multiple SclerosisJustin Killick, Joanne Hay, Elena Morandi, et al.
Cancer Immunology Research|January 15, 2026
Conditional IL4I1 inactivation triggers tumor-associated macrophage reprogramming and CD8+ T-cell reactivation to control melanoma progressionMalvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 23, 2025
Sex Bias in IL-10 Production by Type I Regulatory T Cells Regulated by PI3K/mTOR SignalingAymeline Debonlier, Saniya Kari, Florence Bucciarelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2024
Increased levels of circulating soluble CD226 in multiple sclerosisSaniya Kari, Florence Bucciarelli, Thibault Angles, et al.
Nature Communications|July 2, 2025
In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosisBeatriz Chaves, Juan Carlo Santos E Silva, Helder Nakaya, et al.
Pageof 1